Position in TARS
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$23,197,669
New position
Shares Held
368,568
first reported quarter
Ownership
0.857%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#2
of 14 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 61.01831955025938.ToString("F0")%
Shared 0.ToString("F0")%
None 38.98168044974062.ToString("F0")%
Position in Biotechnology
Healthcare · as of Jun 30, 2026WASATCH ADVISORS LP holds $96,311,805 across 9 Biotechnology names. TARS ranks #1 (24.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TARS |
Tarsus Pharmaceuticals, Inc.
This page
|
368,568 | $23,197,669 | |
| 2 | CCCC |
C4 Therapeutics, Inc.
|
3,522,644 | $16,450,747 | |
| 3 | PHAT |
Phathom Pharmaceuticals, Inc.
|
1,307,247 | $14,183,629 | |
| 4 | VKTX |
Viking Therapeutics, Inc.
|
312,767 | $12,201,040 | |
| 5 | DYN |
Dyne Therapeutics, Inc.
|
443,668 | $9,853,866 | |
| 6 | MGNX |
Macrogenics Inc
|
2,018,881 | $9,327,230 | |
| 7 | IMTX |
Immatics N.V.
|
441,510 | $4,472,496 | |
| 8 | NKTX |
Nkarta, Inc.
|
1,577,847 | $4,465,307 |
All Filings in TARS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,197,669 | 368,568 | Shares | Sole | 2026-07-10 | |
| No filing history on record for this holder in this stock. | ||||||